RIO DE JANEIRO, BRAZIL – According to a report published by The New York Times, the destination of millions of vaccine doses, which have not yet been authorized by the US regulatory agency, is being discussed by White House and Health Department officials.
US government officials are considering sending millions of covid-19 vaccine doses produced by AstraZeneca in partnership with Oxford University to other countries, including Brazil.
According to a report published by The New York Times, the destination of millions of doses of the immunizer, which has not yet been passed by the US regulatory agency, is being discussed by White House and Health Department officials. Some believe that the vaccines should be released to countries that desperately need to bolster their immunization campaigns.
“We are aware that other governments have approached the US government regarding the donation of AstraZeneca doses and are urging the US government to carefully consider these requests,” Gonzalo Viña, a spokesperson for the lab, told the New York Times.
Sources told the newspaper that about 30 million doses of AstraZeneca’s vaccine are in a warehouse in the state of Ohio. However, because the lab has not completed a phase 3 trial in the United States, its emergency use application to the FDA, the country’s regulatory agency, has not yet been made.
The New York Times says that the US government has rejected all requests made so far, but AstraZeneca’s spokesperson said that talks on the donation option are ongoing.
One of the obstacles to donations is US President Biden’s plan to step up the vaccination campaign in the country. In a speech yesterday, he instructed the states to release vaccines to all adults as of May 1st.
When announcing last Wednesday the purchase of another 100 million doses of the Johnson & Johnson vaccine, US president Joe Biden was asked about the prospect of helping other countries and he answered that he would make donations as soon as the USA has the required immunizers to protect the country’s population.
Source: Valor